Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vascarta
AddedFeb 18, 2024
UpdatedJun 18, 2026
Vascarta

Vascarta

Angel

Vascarta: Innovating drug development with novel transdermal technology for the inflammation market.

HQ
Summit, NJ, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Vascarta is a pharmaceutical company focused on innovating drug development through its patented transdermal delivery platform. The company's core mission is to enhance the bioavailability of drugs, botanicals, and dietary supplements, ensuring they reach their therapeutic potential. Vascarta's lead product candidate targets the inflammation market, a sector valued at over $100 billion, aiming to redefine the standard of care with its novel technology.

Vascarta has made significant strides in the pharmaceutical industry with its unique approach to drug delivery. The company's seasoned management team brings extensive experience and expertise, driving the development and potential market success of its products. By addressing the issue of poorly soluble drugs, Vascarta's technology promises to improve patient outcomes and set new benchmarks in drug efficacy and safety.

Vascarta - Similar Companies

TheraVasc logo

TheraVasc

Vitranu logo

Vitranu

vitranu.com

Clear Vascular logo

Clear Vascular

CarthroniX logo

CarthroniX

carthronix.com

Vivasc Therapeutics logo

Vivasc Therapeutics

Vasa Therapeutics logo

Vasa Therapeutics

Vasca logo

Vasca

Qnovia logo

Qnovia

qnovia.com

Orcosa logo

Orcosa

orcosa.com

Transpire Bio logo

Transpire Bio

transpirebio.com

Corsair Pharma logo

Corsair Pharma

corsairpharma.com

Vast Therapeutics logo

Vast Therapeutics

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Transcera logo

Transcera

Traverse Vascular logo

Traverse Vascular

Vascarta - Quick Facts

Who are Vascarta's competitors?

Companies similar to Vascarta include TheraVasc, Vitranu, Clear Vascular and CarthroniX.

When was Vascarta founded?

Vascarta was founded in 2020.

Where is Vascarta's headquarters located?

Vascarta's headquarters is located in Summit, NJ, US.

When was Vascarta's last funding round?

Vascarta's most recent funding round was for $50k (USD) in March 2022.

How much has Vascarta raised to-date?

As of Mar 10, 2022, Vascarta has raised a total of $788.5k (USD).

How many employees does Vascarta have?

Vascarta has 6 employees as of Feb 5, 2024.

Vascarta - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations